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MaTranscatheter ablation of renal autonomic nerves is a viable option for the treatment of resistant arterial hypertension;
however, structured pre-clinical evaluation with standardization of analytical procedures remains a clear gap in this ﬁeld.
Here we discuss the topics relevant to the pre-clinical model for the evaluation of renal denervation (RDN) devices and
report methodologies and criteria toward standardization of the safety and efﬁcacy assessment, including histopatho-
logical evaluations of the renal artery, periarterial nerves, and associated periadventitial tissues. The pre-clinical swine
renal artery model can be used effectively to assess both the safety and efﬁcacy of RDN technologies. Assessment of the
efﬁcacy of RDN modalities primarily focuses on the determination of the depth of penetration of treatment-related injury
(e.g., necrosis) of the periarterial tissues and its relationship (i.e., location and distance) and the effect on the associated
renal nerves and the correlation thereof with proxy biomarkers including renal norepinephrine concentrations and nerve-
speciﬁc immunohistochemical stains (e.g., tyrosine hydroxylase). The safety evaluation of RDN technologies involves
assessing for adverse effects on tissues local to the site of treatment (i.e., on the arterial wall) as well as tissues at a
distance (e.g., soft tissue, veins, arterial branches, skeletal muscle, adrenal gland, ureters). Increasing experience will
help to create a standardized means of examining all arterial beds subject to ablative energy and in doing so enable
us to proceed to optimize the development and assessment of these emerging technologies. (J Am Coll Cardiol Intv
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AB BR E V I A T I O N S
AND ACRONYM S
CGRP = calcitonin gene-
related peptide
H&E = hematoxylin and eosin
RDN = renal denervation
TH = tyrosine hydroxylase
TTC = 2,3,5-
triphenyltetrazolium chloride
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1185introduced as a promising option for the treatment of
resistant hypertension. Indeed, catheter-based radio-
frequency renal denervation (RDN) has demonstrated
effectiveness in clinical studies (3). The increasing
prevalence of patients with resistant hypertension
on a global scale (2) and the appeal of deﬁnitive inter-
vention without lifelong obligate adherence to
repeated drug dosing has generated a ﬁerce demand
to reﬁne current catheter-based RDN procedures and
technologies. To this effect, a variety of technological
innovations such as radiofrequency and ultrasound
catheters, catheter-based microinfusion of neuro-
toxic drugs, and externally applied focused ultra-
sound have been developed, and pre-clinical studies
for those devices are ongoing (4). The main objective
of these technological endeavors pertains to the
effective destruction of periarterial sympathetic
nerves while preserving arterial morphology and
renal function.
In this regard, histopathological assessment of the
renal vasculature, along with biomarker analysis of
hormones and neurotransmitters, surrounding sym-
pathetic nerves and other regional soft-tissue struc-
tures is critically important. However, there remains a
clear lack of standardization with respect to the his-
topathological assessment of these tissues after
denervation procedures. Most recently, the failure of
the ﬁrst randomized, sham-controlled clinical trial
(SYMPLICITY HTN-3 [Renal Denervation in Patients
With Uncontrolled Hypertension]) to reach its pri-
mary efﬁcacy endpoint at 6 months underscores
the need to revisit existing pre-clinical animal models
(5) because there is no marker of procedural efﬁcacy
(i.e., conﬁrmation of effective and complete dener-
vation) in humans. In this regard, we aim to establish
standardized and reproducible methodology and
criteria for histopathological evaluation after renal
sympathetic denervation.
ANIMAL MODEL SYSTEMS
There are a number of means of applying energy to
the arterial bed and a number of animal models in
which such energies can be applied. The early litera-
ture in this ﬁeld dates back to the groundbreaking
work of Goldblatt et al. (6) who in the 1930s imposed
unilateral or bilateral renal arterial constriction to
provoke ischemia and the release of renin to induce
hypertension. Their work in dogs deﬁned renal
vascular hypertension, helped to deﬁne the renin-
angiotensin-aldosterone system, and was followed
soon thereafter by a series of experiments demon-
strating surgical sympathectomy as a possible thera-
peutic intervention. Other renal injury modelsemerged including complete ablation or
excision of a kidney or infusion of neph-
rotoxins systemically or locally (7). Other
species were considered including small
rodents, especially the rat, and occasionally
the rabbit (8). As percutaneous technologies
have emerged, swine has become a preferred
target. Although the bulk of studies are per-
formed in intact animals, it will be increas-
ingly the case that animals with modiﬁed
renal vasculature and preceding hypertension will be
considered. As these models emerge, careful com-
parison to control states must be attained. Such a
deﬁnition needs to include not only architecture at a
deﬁned period of time but the temporal and spatial
kinetics of the dynamics and recognition of systemic
and circulating effects. These models therefore
expand dramatically the tools available to examine
ablative technologies but also simultaneously expand
the challenges of careful and precise delineation of
effects. Disease models necessarily disrupt the
normal architecture, and our view of the normal state
is inadequate. Each applied neurotoxic effect is
accompanied by idiosyncratic changes, and these
must be fully deﬁned before we can proceed with
understanding how therapeutic interventions play a
role. It will now be especially important as well to
track effects over time; we do not know, for example,
whether there is recovery of neural ablation. Clinical
studies seem to foretell sustained effects, but there is
not a deﬁnitive time when recovery is observed or
deemed beyond approach. As disease models are
used, these time-dynamic effects will need to be
pursued further.
PORCINE RENOVASCULAR ANATOMY
Although animal models for the assessment of renal
sympathetic denervation remain under development,
the swine model is the most frequently used because
of its similarity to the renovascular anatomy and
size in humans (9). Nevertheless, descriptions of
porcine perirenal nerve anatomy remain meager. We
examined 11 normal renal arteries from 11 pigs to
elucidate renovascular anatomy in this species. A
total of 6 to 8 sections from each renal artery and
surrounding tissues were sectioned at 4- to 5-mm
intervals after marking with indelible ink of the
ventral (orange), dorsal (black), superior (blue), and
inferior (green) regions and subjected to routine
tissue processing, parafﬁn embedding, sectioning
at 4 to 5 mm, and staining with hematoxylin and
eosin (H&E) and Movat pertachrome stains. Digital
images were prepared from H&E-stained sections
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1186at 1.25 magniﬁcation. Images were divided into 4
quadrants and analyzed using image analysis soft-
ware (IP Lab for Mac OS X, Scanalytics, Rockville,
Maryland). Length measurements from the luminal
surface of the renal artery to the outer nerve contour
were performed in each of the 4 quadrants (ventral,
dorsal, superior, and inferior locations). Representa-
tive images of distance measurements are shown in
Online Figure 1.
The mean length of renal arteries (from the aorta
to renal artery bifurcation after removal and perfu-
sion ﬁxation by 10% formalin) was 2.1  0.5 cm. A
total of 484 nerves from 11 renal arteries were iden-
tiﬁed from 39 sections (mean number of nerves per
section was 12.4  5.7). The mean number of nerves
in segments proximal (10.5  6.2), middle (12.0 
4.4), and distal (14.0  4.4) to the renal aortic ostium
were not signiﬁcantly different, although there was a
trend toward greater nerves in the distal versus
proximal (p ¼ 0.55 for proximal vs. middle, p ¼ 0.06
for proximal vs. distal, p ¼ 0.34 for middle vs. distal).
The mean number of nerves in the ventral location
(4.7  2.3) was signiﬁcantly greater compared with
the dorsal location (2.3  1.1) (p ¼ 0.02), whereas
there was a similar number of nerves in the superior
(3.0  1.8) and inferior (2.1  1.2) (p ¼ 0.19) arterial
location. The cumulative incidence of nerves at dis-
tance from lumen is shown in Figure 1. These data are
somewhat at odds with those of Tellez et al. (10) who,
using renal artery nerve distribution from 5 pigs,FIGURE 1 Cumulative Incidence of Normal Perirenal Nerve Distance
The cumulative incidence of nerve distance from the lumen is calculated
lumen to the nerve was 2.1 mm, whereas the 75th percentile was 4.4 mreported higher nerve density in the proximal seg-
ments compared with that in the middle or distal
segments. Yet both studies conﬁrmed nerve density
in normal swine is less than in diseased humans (11),
and, as such, if these spatial differences continue to
be validated, they will not only inﬂuence the design
of technology but necessitate careful maintenance of
specimen alignment and location before effects can
be adequately described or compared. Pre-clinical
safety assessment including the study of porcine
nerve anatomy is important for a standardized eval-
uation of innovative technology targeted at RDN
therapy. However, the ﬁndings of pre-clinical studies
should be interpreted with caution, as the inﬂuence of
underlying atherosclerosis in human arteries as well as
the depth of the nerve distribution may be different
and cannot be assessed in healthy animal models.
Moreover, as discussed previously, further examina-
tion of diseased animal model systems will likely soon
follow.
NOREPINEPHRINE ANALYSIS
Researchers have determined that catecholamines
such as norepinephrine are important biomarkers
that aid in the evaluation of the efﬁcacy of novel
therapies in many disease states including neuro-
logical disorders, metabolic disease, pain, heart
disease, and more speciﬁcally drug-resistant hyper-
tension. Down-regulation of norepinephrine in renals From the Renal Arterial Lumen
from 484 nerves. The 50th percentile of the distance from the arterial
m.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 7 , N O . 1 0 , 2 0 1 4 Sakakura et al.
O C T O B E R 2 0 1 4 : 1 1 8 4 – 9 3 Methods for Histopathological Evaluation in RDN
1187tissue has been shown to be an indicator of the
efﬁcacy of RDN therapy in the treatment of drug-
resistant hypertension (12,13). The analytical chal-
lenges present in the quantitative analysis of
norepinephrine in renal tissue are signiﬁcant. Nore-
pinephrine is present at extremely low endogenous
levels and is subject to extremely rapid metabolic
and nonmetabolic oxidative degradation. Renal
tissue collection techniques must be optimized to
avoid autolysis, and tissues must be rapidly frozen
before extraction. Tissue sampling techniques must
ensure homogeneous sampling as norepinephrine is
nonuniformly distributed in the kidney. Studies
designed to correlate histopathological ﬁndings with
norepinephrine levels must further combine rapid
sampling and stabilization of kidney tissue to avoid
norepinephrine degradation and perfusion ﬁxation
of the arterial and periarterial tissue to optimize
nerve assessment.
Historical analytical methods of detection of
norepinephrine have typically used high-pressure
liquid chromatography coupled with electrochemical
detection (14). High-pressure liquid chromatography
coupled with electrochemical detection affords high
sensitivity but lacks mass speciﬁcity and is therefore
subject to potential interferences from a large num-
ber of endogenous and exogenous compounds.
The preferred method to quantify norepinephrine
in swine renal tissue in the subendogenous range is
high-throughput tandem mass spectrometry (15).
Mass speciﬁcity provides the ability to differentiate
norepinephrine from epinephrine and other endoge-
nous catecholamines. Methods that use a stable
isotope-labeled analyte (16), norepinephrine D6, as a
surrogate reference standard can leverage the fact
that the deuterium-labeled norepinephrine and un-
labeled norepinephrine behave uniformly during
extraction, chromatography, and tandem mass spec-
troscopy ionization conditions. Extraction and ho-
mogenization of norepinephrine from pig kidney
tissue must use a solution that helps to enhance the
stability of norepinephrine. Through the use of the
stable labeled compounds high-throughput tandem
mass spectrometry can be used to determine norepi-
nephrine at >2 orders of magnitude below endoge-
nous levels. Tissue norepinephrine concentrations in
the kidney of the treated arteries are then compared
with the tissue norepinephrine concentration in the
contralateral untreated kidney or to a pool of control
animals (Online Figure 2), and norepinephrine data
are presented as the percentage of norepinephrine
reduction from control.
Methods of ﬁxation and tissue dissection are
described in the Online Appendix.MACROSCOPIC 2,3,5-
TRIPHENYLTETRAZOLIUM CHLORIDE
STAINING
It is useful in the early phase of energy-based ablative
device development to macroscopically examine the
luminal surface of acutely treated renal arteries using
2,3,5-triphenyltetrazolium chloride (TTC) staining.
TTC is not a true stain but a water-soluble salt that is
enzymatically reduced by living cells to a formazan
compound that imparts a visibly red coloration (17).
TTC staining has been used for decades in research
models for the detection and identiﬁcation of tissue
injury/necrosis (e.g., myocardial [18] or cerebral [19]
infarction) as nonviable cells lack functional enzy-
matic processes and do not “stain” but remain pale,
in stark contrast to the intensely red coloration of
adjacent viable tissue. As such, the exposure of the
lumen of acutely treated renal arteries to a TTC so-
lution allows the precise delineation of the “foot-
print” of the energy modality and allows one to make
macroscopic measurements and correlations with
device and histological parameters.
HISTOPATHOLOGICAL AND
IMMUNOHISTOCHEMICAL STAINS
Treatment-related soft-tissue damage can sometimes
be visualized grossly during dissection; however,
arterial, nerve, and soft-tissue damages are best
visualized on H&E-stained sections. Additional stains
of elastic ﬁbers (e.g., elastica van Gieson, Movat
pentachrome, or Mallory trichrome stains) are en-
couraged as these may provide helpful information
with regard to changes in arterial morphology and
tissue responses. Immunohistochemical staining for
nerve fascicles should be considered in selected sec-
tions to evaluate for changes in neurotransmitters or
axonal degeneration. Immunostains against S-100
protein (a marker for Schwann and sustentacular
cells), neuroﬁlament protein (a marker for neurons
and ganglion cells), and glial ﬁbrillary acidic protein
(a marker for glial cells) are used for the recognition of
nerve fascicles (20), whereas stains targeted at tyro-
sine hydroxylase (TH), which converts tyrosine to
L-DOPA, are used for the presence or absence of
norepinephrine synthesis (21). Although L-DOPA de-
carboxylase (which converts L-DOPA to dopamine) is
another catecholamine-synthesizing enzyme, immu-
nostaining against L-DOPA decarboxylase is rarely
used in the area of RDN because L-DOPA decarbox-
ylase–positive ﬁbers are more sparsely distributed
than TH-positive ﬁbers in perivascular nerves in the
kidney (22). The combination of at least 1 axonal
FIGURE 2 Semiqua
(Upper) Representat
in each grade. (Lowe
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1188marker (S-100 protein, neuroﬁlament protein, or glial
ﬁbrillary acidic protein) and a functional marker (TH)
may provide meaningful insights into the functional
relevance of ablative treatment against resistant
hypertension.
Periarterial nerves around the kidney comprise
efferent (sympathetic) nerve ﬁbers and afferent
(sensory) nerve ﬁbers, and both types of nerves may
affect renal sympathetic nerve activity (23). To iden-
tify renal afferent nerves, immunostains against
calcitonin gene-related peptide (CGRP) and substance
P, which serve as neurotransmitters in sensory nerves
(24), have been reported in the literature. However,
because immunostaining for CGRP using color-
producing reagents has been reported to result in
low intensity, the more reliably strong intensity ofntitative Grading Scheme for Nerve Changes
ive images of nerves by increasing grade of injury. (Middle) High-power image
r) Representative images of vacuolization, pyknotic nuclei, digestion chambersTH is most often adopted for staining of efferent
sympathetic nerve ﬁbers in the immunohistochemical
assessment of successful ablation of periarterial sym-
pathetic nerves (10). Most importantly, the intensity
of color reaction has been shown to be correlated
with presence of viable efferent sympathetic nerve
ﬁbers using TH staining (21), an association not
found with other immunostain procedures such as
CGRP and substance P.
EVALUATION
HISTOLOGIC ASSESSMENT OF NERVE FASCICLES.
Treatment-related changes to periarterial nerves can
be assessed using a semiquantitative ordinal grading
system that allows the assessment of the type ofs of injured nerves (red boxed area in upper panel)
, and perineural ﬁbrosis. Hematoxylin and eosin staining.
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1189change (e.g., degeneration, necrosis, chronic) and its
magnitude (e.g., minimal, mild, moderate, severe).
Figure 2 provides a representative grading scheme that
refers to effects on both peri- and endoneuronal tissue.
The type and magnitude of changes in periarterial
nerves can represent damage incurred directly with
the treatment in the plane of section (i.e., nerves that
lie directly in the path of treatment) or represent
changes associated with injury to the nerve along its
length outside the plane of section (i.e., upstream or
downstream injury). Treatment may affect the peri-
neuronal and/or endoneuronal portions of the renal
nerves and present as degenerative, necrotic, or
chronic changes. Degenerative changes associated
with perineuronal or endoneuronal injurymay include
vacuolization and the formation of digestion chambers
associatedwith injury, reversible or irreversible, to the
axonal processes of the treated nerve. Necrotic
changes may range from pyknosis/karyorrhexis of in-
dividual neural nuclei to coagulative necrosis or frank
coagulation of the nerve bundle. After resolution of
the acute phase of treatment, affected nerves may
exhibit a variety of chronic changes including peri- and
endoneural ﬁbrosis, axonal atrophy, and loss. With
minimal injury (i.e., grade 1), the nerve would be
considered largely intact and likely functional, but
exhibit subtle signs of damage that may include trivial
perineuronal inﬂammation or hemorrhage and limited
endoneuronal damage (perineuronal proteoglycan
deposition, ﬁbroplasia with little to no vacuolization,
pyknosis, or increase in cellularity). With mild injury
(i.e., grade 2), changes are more conspicuous and/or
involve more of the nerve bundle and may include
increased cellularity, perineuronal inﬂammation,
ﬁbrosis, and/or endoneuronal changes (e.g., vacuoli-
zation, pyknotic nuclei, digestion chambers). Nerves
with moderate injury (i.e., grade 3) would be inter-
preted to exhibit more notable changes that may
include perineuronal inﬂammation, ﬁbrosis as well
as endoneuronal damage (frequent pyknotic nuclei,
digestion chambers, vacuolization, or swelling of
endoneuronal tissue). Severe injury (i.e., grade
4) changes are typically overwhelming and may
consist of marked perineuronal inﬂammation and/or
ﬁbrosis and endoneurium damage including efface-
ment of nerve architecture, necrosis, and axonal
retraction. Becauseminimal ormild injury (i.e., grade 2
or lower) can be seen even in untreated animals,
moderate or severe injury (i.e., grade 3 or higher)
should be considered a deﬁnite injury caused by
thermal damage or toxins and generally correlates
with decreases in renal norepinephrine levels.
Regardless of scoring methodology, the location of
all observed nerves should be denoted relative to thearea of the treatment (i.e., within or outside the zone
of treatment) for the purposes of better understand-
ing the treatment efﬁcacy on the total population of
nerves available for treatment.
IMMUNOSTAINING OF PERIVASCULAR
NERVES AND SCORING CRITERIA
The intensity and distribution of immunostaining
can be assessed using a semiquantitative scoring
system (e.g., 0 ¼ no reaction, 1 ¼ patchy/very weak
reaction, 2 ¼ weak to moderate reaction, 3 ¼ strong
reaction). Representative images of immunostaining
are shown in Figure 3. Typically, a weak reaction
(i.e., grade 2 or lower) or the absence of TH repre-
sents a strong treatment effect as the absence of
staining is an indirect sign of functional nerve
degeneration and can be correlated with the renal
norepinephrine levels. With respect to the func-
tional assessment of nerve viability using immuno-
staining, the choice of time point is crucial as
immunohistochemical analysis represents a snapshot
assessment in the time course of axonal degeneration
after RDN procedures. If the nerves being examined
after <7 days of denervation, immunostaining
is usually positive despite extensive necrosis; there-
fore, it is not recommended that immunostaining be
performed before 7 days after the denervation
procedure.
HISTOLOGICAL ASSESSMENT OF
RENOVASCULAR MORPHOLOGY
Renovascular damage includes endothelial cell loss,
thrombus formation, and medial damage, which
can be assessed along the depth and circumference
of the artery. These changes can be assessed using
a semiquantitative ordinal grading system (e.g.,
0 ¼ none, 1 ¼ minimal, 2 ¼ mild, 3 ¼ moderate,
4 ¼ severe). Figure 4 provides representative
images of a grading scheme that refers to both
endothelial cell loss and medial wall damage.
Endothelial cell loss should be evaluated by the
percentage of circumferential endothelial cell loss
(Figure 4). Endothelial cell loss is typically observed
acutely after treatment and is rarely observed at
28 days. A common characteristic of thermal medial
injury is smooth muscle cell loss/necrosis with
proteoglycan and/or ﬁbrous tissue replacement.
The depth of medial damage is evaluated by the
percentage of smooth muscle cell loss in relation to
medial thickness (Figure 4). When evaluating the
depth of medial damage, the presence of medial
thinning should be reported. Medial thinning is
FIGURE 3 Semiquantitative Scoring Criteria for Immunostain Against Tyrosine Hydroxylase
(First Row) Representative images of injured nerves stained by anti–tyrosine hydroxylase (TH) enzyme. (Second Row) Corresponding images of injured nerves with
S-100. (Third Row) Corresponding images of injured nerves with hematoxylin and eosin (H&E) stain. (Fourth Row) Corresponding images of injured nerves with
Movat pentachrome stain.
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1190deﬁned as thickness of the media at the site of
damage (in millimeters)/unaffected media thickness
(in millimeters) with <0.5 representing severe smooth
muscle cell loss/necrosis within the media. In addi-
tion, the cross-sectional dimension of medial damage
can be assessed as circumferential loss/necrosis of
smooth muscle cells. When evaluating medial
damage, it is recommended to use the Movat pen-
tachrome stain as proteoglycan deposition can be
easily appreciated.
HISTOLOGICAL ASSESSMENT FOR
PERIARTERIAL TISSUES AND ORGANS
Periarterial tissues such as fat, collagen, renal veins,
arterioles, ureters, adrenal glands, skeletal muscle,viscera, and the kidneys should all be systematically
evaluated for signs of injury. Again, a semiquanti-
tative ordinal grading system (e.g., 0 ¼ none,
1 ¼ minimal, 2 ¼ mild, 3 ¼ moderate, 4 ¼ severe) can
be used to score observed changes. It is important to
mention that the risk of thermal renal vein injury
and thrombosis is far less than that of thermal
arterial injury. Also, most venous injuries start at the
abluminal surface, whereas most of arterial injuries
begin at the luminal surface, depending, of course,
on the mode of denervation used. However, as the
veins are thin, it is important to appropriately assess
the venous injury and/or thrombosis. Arteriolar
damage usually correlates with the overall nerve
damage. Typical severe (grade 4) injury of arterioles
is ﬁbrinoid necrosis, which is most often observed
FIGURE 4 Semiquantitative Grading Scheme for Renal Artery Damage
(Upper) Images of the depth of medial wall injury by the grade of damage. (Lower) Represent circumferential grade of the damage of the medial wall. Note that medial
thinning can only occur with grade 4 depth of injury and should be distinguished. All images are stained with Movat pentachrome.
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1191acutely but often persists as long as 28 days.
Representative scoring criteria for arteriole damage
is shown in Online Figure 3. Injury to the ureters is
evaluated by the extent of edema and necrosis
(submucosal, muscular, and periureteral surround-
ing tissue) as well as mucosal ulceration. However,
ureter injury is not frequent because the remote
anatomic position of the ureter relative to the
ablation site precludes it from direct thermal injury.
As a direct sign of thermal injury of collagen/adi-
pose tissue, the presence of denatured collagen
should be assessed, which can easily be detected by
elastica stains. Similarly, periadventitial fat may
undergo necrosis with saponiﬁcation and surround-
ing acute inﬂammation followed by chronic inﬂam-
mation (25,26). This usually appears as a shadowy
outline of adipose cells with saponiﬁcation.Representative scoring criteria for fat damage are
shown in Online Figure 4.
Not only are direct renal and soft tissue important,
but attention should be also directed to lymph node
damage, skeletal muscle, and adjoining viscera (e.g.,
the cecum and adrenal glands). Therefore, these
structures should be routinely assessed by the indi-
vidual necropsy prosector and submitted for histo-
logical assessment for the extent and type of damage,
if present.
ADVANTAGE OF THE COMBINATION OF
VARIOUS STAINS
The combination of an elastica stain with a standard
H&E stain will more reliably allow the appropriate
assessment of nerve injury, arterial wall injury, and
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1192soft-tissue injury (Online Figure 5) as the information
provided by both staining protocols is cumulative.
For example, proteoglycan replacement (green tis-
sue) within the arterial media can easily be recog-
nized by a Movat pentachrome stain. Denatured
collagen is clearly distinguished as black tissue by
Movat pentachrome stain, whereas H&E gives a blue
tinge of staining and may be difﬁcult to identify.
Also, perineural ﬁbrosis can easily be recognized by
Movat pentachrome stain. Therefore, we recommend
using this stain as well as H&E routinely for the
evaluation of arterial, soft-tissue, and nerve injuries.
QUADRANT ANALYSIS AND
DEEPEST SOFT-TISSUE DAMAGE
To capture the entire spectrum of thermal and/or
toxic tissue damage along the vascular circumfer-
ence, a cross-sectional quadrant analysis is recom-
mended, as shown in Online Figure 6, in which 1FIGURE 5 Representative Images of the Distance From the Arterial
(A) Low-power image of a treated renal artery and surrounding perirena
in A). The distance from the lumen to injured arterioles was 4.4 mm. (C
distance from the lumen to injured nerves was 2.1 mm. (D) High-power i
lumen to injured nerves was 4.1 mm. (E) High-power image of soft-tissue
tissue was 3.2 mm.quadrant refers to <25% circumferential area, 2
quadrants refer to 26% to 50% circumferential area,
3 quadrants refer to 51% to 75% circumferential area,
and 4 quadrants refer to >75% circumferential area.
Obtaining the number of quadrants with injured
nerve fascicles relative to quadrants with the pres-
ence of nerve fascicles enables the capturing of
differences in circumferential thermal injury among
different devices. The distance from renal arterial
lumen to the deepest tissue damage (nerves, vein,
arterioles, or other soft tissues) determines the
effective depth of thermal and/or toxic injury among
different devices. Figure 5 shows representative
images of distance measurements. Combining the
information retrieved from cross-sectional quadrant
analysis and penetration of the depth of thermal
injury provides unique information regarding the
number of quadrants affected and the adequacy of
the denervated area in relation to circumferential
discontinuity of innervation of the kidney.Lumen to Various Types of Injury
l area. (B) High-power images of injured arterioles (red boxed area
) High-power image of nerve injury (yellow boxed area in A). The
mage of injured nerves (blue boxed area in A). The distance from the
injury (green boxed area in A). The distance from the lumen to injured
TABLE 1 Summary of Methodological Standard for the Pre-Clinical Evaluation
of Renal Sympathetic Denervation
Category Methods Purpose
Biomarker Kidney norepinephrine levels
(high-throughput tandem
mass spectrometry)
Evaluation of the extent of renal
sympathetic denervation
Macroscopic evaluation TTC staining of renal artery To assess the extent of arterial
wall injury
Standard light
microscopy and
morphometry
Semiquantitative scoring of
pathological changes (grade
0 to grade 4): nerve, renal
artery, vein, arterioles, fat,
and collagen
To determine the extent of
nerve injury and arterial
and surrounding soft-tissue
injury
Quadrant analysis (0 to 4
quadrants) for nerve injury
and soft-tissue injury
Evaluation of circumferential
extent of injury
Depth of tissue injury, mm Evaluation of therapeutic
penetration
Immunohistochemistry Semiquantitative scoring of
intensity of immunostaining
(score 0 to score 3) by
anti–tyrosine hydroxylase
Evaluation of the ability of
the nerves to generate
norepinephrine (functional
nerve injury)
TTC ¼ 2,3,5-triphenyltetrazolium chloride.
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1193SUMMARY
A summary of methodological standard for the pre-
clinical evaluation of RDN is shown in Table 1. The
purpose of this paper is to guide and standardize the
pre-clinical histopathological assessment with regard
to renal sympathetic denervation procedures. Stan-
dardization of histopathological assessment remains
an unmet need in this ﬁeld, which may ultimately
facilitate understanding of underlying mechanisms
after RDN and further to help to assess which device
is the more appropriate and what advantages each
device may offer from the currently available tech-
nologies. As research in this area evolves, updates
will be mandatory to warrant appropriate adoption
into clinical practice.
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